| General Practice | Intellectual Property Law |
| Labor and Employment Law | |
|
|
Learn More |
Martindale-Hubbell has augmented a firm's provided information with third-party sourced data to present a more comprehensive overview of the firm's expertise:
U.S. Federal Litigation Activity
Highest number of cases by Foley Hoag LLP:
Intellectual Property (25 cases in past two years)
Transactional Activity
Total number of Mergers & Aquisitions by Foley Hoag LLP:
4 (in past two years)
U.S. Patent Activity
Total number of U.S. granted patents by Foley Hoag LLP:
157 (in past two years)
Peer Review Ratings
Total number of Peer Review Rated lawyers of Foley Hoag LLP:
68
Documents by Foley Hoag LLP on Martindale.com
| |
FDA Releases Long-Awaited Draft Guidances on Biosimilar Product DevelopmentBarbara A. Fiacco,James M. Flaherty,Paul T. Kim,Donald R. Ware, February 13, 2012
Today, the U.S. Food and Drug Administration (FDA) released three draft guidance documents designed to assist industry in developing biosimilars. Biosimilar products are biological products shown to be highly similar (biosimilar) to biological products previously approved by FDA (known as...
FDA’s Draft Guidance on Scientific Considerations in Demonstrating BiosimilarityBarbara A. Fiacco,James M. Flaherty,Paul T. Kim,Donald R. Ware, February 13, 2012
Yesterday, the U.S. Food and Drug Administration released three draft guidance documents designed to assist industry in developing biosimilars and implementing the new abbreviated biologics approval pathway under section 351(k) of the Biologics Price Competition and Innovation Act of 2009 (BPCI...